EMERGENCE OF RESISTANCE AFTER THERAPY WITH ANTIBIOTICS USED ALONE OR COMBINED IN A MURINE MODEL

[1] BRYSON V, 1952, SCIENCE, V116, P45, DOI 10.1126/science.116.3003.45

[2] CIPROFLOXACIN, A QUINOLONE CARBOXYLIC-ACID COMPOUND ACTIVE AGAINST AEROBIC AND ANAEROBIC-BACTERIA [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) : 319 - 326

[3] FREQUENCY OF APPEARANCE OF RESISTANT VARIANTS TO NORFLOXACIN AND NALIDIXIC-ACID [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 : 33 - 38

[4] INVIVO AND INVITRO EMERGENCE OF SIMULTANEOUS RESISTANCE TO BOTH BETA-LACTAM AND AMINOGLYCOSIDE ANTIBIOTICS IN A STRAIN OF SERRATIA-MARCESCENS [J]. ANNALES DE MICROBIOLOGIE, 1983, A134 (03): : 329 - 337

[5] DIFFERENT MECHANISMS OF RESISTANCE TO LATAMOXEF (MOXALACTAM) IN SERRATIA-MARCESCENS [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 (01) : 15 - 22

[6] CROSS-RESISTANCE TO NALIDIXIC-ACID, TRIMETHOPRIM, AND CHLORAMPHENICOL ASSOCIATED WITH ALTERATIONS IN OUTER-MEMBRANE PROTEINS OF KLEBSIELLA, ENTEROBACTER, AND SERRATIA [J]. JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (03) : 501 - 507

[7] THE INVITRO ACTIVITY OF CIPROFLOXACIN COMPARED WITH THAT OF NORFLOXACIN AND NALIDIXIC-ACID [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 (04) : 325 - 331

[8] KLASTERSKY J, 1984, ANTIMICROBIAL THERAP, P37

[9] EMERGENCE OF RESISTANCE TO BETA-LACTAM AND AMINOGLYCOSIDE ANTIBIOTICS DURING MOXALACTAM THERAPY OF PSEUDOMONAS-AERUGINOSA INFECTIONS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (06) : 1037 - 1041

[10] RESISTANCE OF PSEUDOMONAS-AERUGINOSA PAO TO NALIDIXIC-ACID AND LOW-LEVELS OF BETA-LACTAM ANTIBIOTICS - MAPPING OF CHROMOSOMAL GENES [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (02) : 242 - 249

[1] BRYSON V, 1952, SCIENCE, V116, P45, DOI 10.1126/science.116.3003.45

[2] CIPROFLOXACIN, A QUINOLONE CARBOXYLIC-ACID COMPOUND ACTIVE AGAINST AEROBIC AND ANAEROBIC-BACTERIA [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) : 319 - 326

[3] FREQUENCY OF APPEARANCE OF RESISTANT VARIANTS TO NORFLOXACIN AND NALIDIXIC-ACID [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 : 33 - 38

[4] INVIVO AND INVITRO EMERGENCE OF SIMULTANEOUS RESISTANCE TO BOTH BETA-LACTAM AND AMINOGLYCOSIDE ANTIBIOTICS IN A STRAIN OF SERRATIA-MARCESCENS [J]. ANNALES DE MICROBIOLOGIE, 1983, A134 (03): : 329 - 337

[5] DIFFERENT MECHANISMS OF RESISTANCE TO LATAMOXEF (MOXALACTAM) IN SERRATIA-MARCESCENS [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 (01) : 15 - 22

[6] CROSS-RESISTANCE TO NALIDIXIC-ACID, TRIMETHOPRIM, AND CHLORAMPHENICOL ASSOCIATED WITH ALTERATIONS IN OUTER-MEMBRANE PROTEINS OF KLEBSIELLA, ENTEROBACTER, AND SERRATIA [J]. JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (03) : 501 - 507

[7] THE INVITRO ACTIVITY OF CIPROFLOXACIN COMPARED WITH THAT OF NORFLOXACIN AND NALIDIXIC-ACID [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 (04) : 325 - 331

[8] KLASTERSKY J, 1984, ANTIMICROBIAL THERAP, P37

[9] EMERGENCE OF RESISTANCE TO BETA-LACTAM AND AMINOGLYCOSIDE ANTIBIOTICS DURING MOXALACTAM THERAPY OF PSEUDOMONAS-AERUGINOSA INFECTIONS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (06) : 1037 - 1041

[10] RESISTANCE OF PSEUDOMONAS-AERUGINOSA PAO TO NALIDIXIC-ACID AND LOW-LEVELS OF BETA-LACTAM ANTIBIOTICS - MAPPING OF CHROMOSOMAL GENES [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (02) : 242 - 249